A Phase 1, First-in-Human, Open-Label, Dose-Escalation and Expansion Study of IMGN151 (anti-FRα antibody-drug conjugate) in Adult Patients with Recurrent Gynaecological Cancers

Project: Research

Project Details

StatusActive
Effective start/end date17/06/25 → 16/06/30

Clinical Trial Phase

  • Phase I
  • External Sponsor